Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT02360956

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02360956
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02360956. Randomized; single masking; primary purpose treatment. Start 2014-12 (registry gives no type); primary completion 2016-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)
Condition
Coronary Atherosclerosis
Intervention (Drug)
Olmesartan medoxomil tablets
Intervention (Drug)
Antihypertensive medication (per doctor suggestion)
Lead sponsor
Chinese PLA General Hospital (class: other)

Record details

Record id
cardio:ct-nct02360956
Content hash
26f3ad21a78d8f50dd2d802226ce53a9738ef98d61444d174b0cf29d39b4fc9a